All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ZENTALIS PHARMACEUTICALS, INC. Last Reported: 6/30/2024 Stock Symbol: ZNTL

Business Address

1359 BROADWAY, SUITE 801

NEW YORK , NY US 10018

Mailing Address

1359 BROADWAY, SUITE 801

NEW YORK , NY US 10018
Phone Number: (212) 433-3791 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 12/31/2017
Cash and Cash Equivalents $37,616,000.00 $28,038,000.00 $110,751,000.00 $266,558,000.00 $36,280,000.00 $43,069,000.00 $42,551,000.00 $55,143,000.00 $30,572,000.00 $59,714,000.00 $40,807,000.00 $49,170,000.00 $54,951,000.00 $92,552,000.00 $96,016,000.00 $63,650,000.00 $67,246,000.00 $80,526,000.00 $8,738,000.00 $16,107,000.00 $25,154,000.00 --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- $4,000.00 $108,000.00 $5,000.00 $417,000.00 $122,000.00 $73,000.00 $139,000.00 $140,000.00 -- -- -- $917,000.00 --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $14,822,000.00 $13,799,000.00 $11,627,000.00 $10,943,000.00 $17,707,000.00 $14,562,000.00 $12,164,000.00 $12,405,000.00 $11,670,000.00 $10,636,000.00 $10,423,000.00 $8,301,000.00 $6,182,000.00 $5,178,000.00 $5,217,000.00 $2,220,000.00 $1,505,000.00 -- -- -- $606,000.00 --
Total Current Assets $503,806,000.00 $496,718,000.00 $528,264,000.00 $563,929,000.00 $410,226,000.00 $451,933,000.00 $433,890,000.00 $467,626,000.00 $301,282,000.00 $350,770,000.00 $377,565,000.00 $259,449,000.00 $345,104,000.00 $372,736,000.00 $238,481,000.00 $66,009,000.00 $68,891,000.00 -- -- -- $26,677,000.00 --
Property Plant and Equipement $5,679,000.00 $5,819,000.00 $6,393,000.00 $6,650,000.00 $6,880,000.00 $7,705,000.00 $8,027,000.00 $8,218,000.00 $8,480,000.00 $8,148,000.00 $4,698,000.00 $2,251,000.00 $1,099,000.00 $471,000.00 $481,000.00 $519,000.00 $501,000.00 -- -- -- $260,000.00 --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 $3,736,000.00 -- -- -- $3,736,000.00 --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $557,479,000.00 $551,688,000.00 $585,715,000.00 $621,444,000.00 $489,342,000.00 $539,310,000.00 $529,193,000.00 $567,856,000.00 $405,677,000.00 $454,507,000.00 $435,081,000.00 $283,962,000.00 $365,555,000.00 $393,233,000.00 $257,217,000.00 $87,629,000.00 $87,481,000.00 -- -- -- $40,998,000.00 --
Accounts Payable $10,502,000.00 $14,926,000.00 $14,264,000.00 $12,305,000.00 $12,818,000.00 $11,247,000.00 $9,820,000.00 $12,041,000.00 $13,163,000.00 $11,590,000.00 $8,046,000.00 $8,273,000.00 $8,661,000.00 $5,437,000.00 $4,217,000.00 $7,019,000.00 $4,289,000.00 -- -- -- $3,431,000.00 --
Accrued Liabilities $44,296,000.00 $54,441,000.00 $44,654,000.00 $39,454,000.00 $43,540,000.00 $45,400,000.00 $44,241,000.00 $36,595,000.00 $30,322,000.00 $32,354,000.00 $31,369,000.00 $25,304,000.00 $19,940,000.00 $18,469,000.00 $11,350,000.00 $9,920,000.00 $10,608,000.00 -- -- -- $2,554,000.00 --
Total Current Liabilities $98,708,000.00 $114,297,000.00 $103,818,000.00 $98,162,000.00 $103,677,000.00 $105,286,000.00 $100,455,000.00 $95,033,000.00 $90,011,000.00 $90,025,000.00 $41,085,000.00 $36,353,000.00 $32,178,000.00 $27,400,000.00 $19,292,000.00 $20,886,000.00 $19,060,000.00 -- -- -- $8,692,000.00 --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $773,000.00 $2,194,000.00 $-359,000.00 $-338,000.00 $-556,000.00 $-1,353,000.00 $-2,270,000.00 $-1,779,000.00 $-1,109,000.00 $-125,000.00 $32,000.00 $94,000.00 $36,000.00 $23,000.00 $4,000.00 -- -- -- -- -- -- --
Accumulated Deficit $-878,488,000.00 $-888,556,000.00 $-827,639,000.00 $-772,111,000.00 $-659,584,000.00 $-596,365,000.00 $-541,394,000.00 $-486,993,000.00 $-418,636,000.00 $-359,559,000.00 $-309,500,000.00 $-305,309,000.00 $-200,834,000.00 $-160,531,000.00 $-125,976,000.00 $-99,119,000.00 $-82,993,000.00 -- -- -- $-37,330,000.00 --
Total Stockholders' Equity $458,771,000.00 $437,284,000.00 $481,768,000.00 $523,141,000.00 $385,487,000.00 -- $428,504,000.00 $472,490,000.00 $315,298,000.00 -- $393,432,000.00 $223,845,000.00 -- -- -- -- -- -- -- -- -- --
Controlling Interest in Subsidiaries -- $107,000.00 $129,000.00 $141,000.00 $178,000.00 -- $234,000.00 $333,000.00 $368,000.00 -- $564,000.00 $23,764,000.00 -- -- -- $6,712,000.00 $6,821,000.00 -- -- $7,216,000.00 $7,536,000.00 $9,885,000.00
Total Liabilities and Equity $557,479,000.00 $551,688,000.00 $585,715,000.00 $621,444,000.00 $489,342,000.00 $539,310,000.00 $529,193,000.00 $567,856,000.00 $405,677,000.00 $454,507,000.00 $435,081,000.00 $283,962,000.00 $365,555,000.00 $393,233,000.00 $257,217,000.00 $87,629,000.00 $87,481,000.00 -- -- -- $40,998,000.00 --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- $14,000.00 --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $49,585,000.00 $189,590,000.00 $138,033,000.00 $91,268,000.00 $48,584,000.00 $172,734,000.00 $42,181,000.00 $89,937,000.00 $46,112,000.00 $38,439,000.00 $137,162,000.00 $83,164,000.00 $29,521,000.00 $55,380,000.00 $30,710,000.00 $13,258,000.00 $11,869,000.00 $10,739,000.00 $15,778,000.00 $7,089,000.00 $18,921,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $65,325,000.00 $299,509,000.00 $231,587,000.00 $168,869,000.00 $64,953,000.00 $227,287,000.00 $175,533,000.00 $121,340,000.00 $57,879,000.00 $48,193,000.00 $62,870,000.00 $105,479,000.00 $40,245,000.00 $34,767,000.00 $27,376,000.00 $16,399,000.00 $46,845,000.00 $31,940,000.00 $10,635,000.00 $8,722,000.00 $23,797,000.00 --
Loss from Operations $-24,765,000.00 $-299,509,000.00 $-62,718,000.00 $-168,869,000.00 $-64,953,000.00 $-227,287,000.00 $-175,533,000.00 $-63,461,000.00 $-57,879,000.00 $-48,193,000.00 $-62,870,000.00 $-105,479,000.00 $-118,787,000.00 $-78,542,000.00 $-27,376,000.00 $-16,399,000.00 $-46,845,000.00 $-12,583,000.00 $-19,357,000.00 $-8,722,000.00 $-23,783,000.00 --
Loss Before Income Taxes -- $-292,906,000.00 -- -- -- $-237,582,000.00 $-172,778,000.00 $-63,037,000.00 $-57,453,000.00 $-48,105,000.00 $-11,189,000.00 $-105,265,000.00 $-39,930,000.00 $-34,647,000.00 $-27,292,000.00 $-16,235,000.00 $-46,363,000.00 $-31,817,000.00 $-19,246,000.00 $-8,660,000.00 $-23,428,000.00 --
Earnings Per Share Basic $0.14 $-4.47 $-0.79 $-1.85 $-1.07 $-4.48 $-0.96 $-1.34 $-1.31 $-1.11 $-2.59 $-2.58 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 70,898,000 65,409,000 70,612,000 60,038,000 59,277,000 52,857,000 56,807,000 51,117,000 45,244,000 42,688,000 44,609,000 40,549,000 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $0.14 $-4.47 $-3.64 $-1.85 $-1.07 $-4.48 $-0.96 $-1.34 $-1.31 -- $-2.59 $-2.58 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 71,192,000 65,409,000 63,601,000 60,038,000 59,277,000 52,857,000 51,098,000 51,117,000 45,244,000 42,688,000 41,918,000 40,549,000 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 -- -- -- 250,000,000 --
Common Stock Shares Outstanding 71,011,982 70,765,554 70,640,684 70,603,663 59,442,342 59,280,247 57,002,314 56,969,118 45,583,900 45,490,764 45,198,528 41,314,864 41,040,286 40,614,453 35,878,108 -- 24,147,270 -- -- -- 24,147,270 5,187,554
Common Stock Value $70,000.00 $70,000.00 $70,000.00 $70,000.00 $59,000.00 $59,000.00 $57,000.00 $57,000.00 $46,000.00 $45,000.00 $45,000.00 $41,000.00 $41,000.00 $41,000.00 $36,000.00 -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com